Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC lessened its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 17.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 254,474 shares of the company's stock after selling 54,908 shares during the quarter. Voya Investment Management LLC owned approximately 0.13% of Alignment Healthcare worth $2,863,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. R Squared Ltd bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $55,000. RiverPark Advisors LLC bought a new position in shares of Alignment Healthcare during the fourth quarter valued at approximately $106,000. Tower Research Capital LLC TRC raised its position in shares of Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after purchasing an additional 6,286 shares during the period. Ballentine Partners LLC bought a new stake in shares of Alignment Healthcare in the 4th quarter worth approximately $121,000. Finally, Aigen Investment Management LP acquired a new position in Alignment Healthcare during the 4th quarter valued at approximately $129,000. Institutional investors own 86.19% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on ALHC shares. UBS Group boosted their price target on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a report on Friday. Stephens restated an "overweight" rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Monday, February 24th. Bank of America lifted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a report on Tuesday, March 4th. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. Finally, Barclays lifted their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a research note on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $17.17.

Alignment Healthcare Trading Down 7.4 %

Shares of ALHC stock opened at $15.53 on Friday. The stock has a 50-day simple moving average of $17.27 and a 200 day simple moving average of $14.28. The stock has a market capitalization of $3.07 billion, a P/E ratio of -20.17 and a beta of 1.32. Alignment Healthcare, Inc. has a fifty-two week low of $5.62 and a fifty-two week high of $21.06. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company had revenue of $926.93 million during the quarter, compared to analyst estimates of $889.83 million. During the same quarter last year, the firm posted ($0.25) EPS. The business's revenue for the quarter was up 47.5% on a year-over-year basis. On average, sell-side analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, insider Christopher J. Joyce sold 25,000 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $16.87, for a total transaction of $421,750.00. Following the completion of the sale, the insider now directly owns 390,022 shares of the company's stock, valued at approximately $6,579,671.14. This represents a 6.02 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Andreas P. Wagner sold 14,878 shares of the company's stock in a transaction that occurred on Wednesday, February 12th. The shares were sold at an average price of $14.38, for a total transaction of $213,945.64. Following the completion of the sale, the insider now owns 200,885 shares of the company's stock, valued at approximately $2,888,726.30. This trade represents a 6.90 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,181,855 shares of company stock valued at $35,166,057. Corporate insiders own 6.60% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.